Optimizing malaria treatment for children with severe malnutrition and adults with HIV
Official title: Informing optimal dosing of the future antimalarial, artemether-lumefantrine plus amodiaquine, in key neglected target populations of children with severe acute malnutrition and adults living with HIV
Funded at Kamuzu University of Health Sciences · NIH-10979190 · Data updated 2026-11-12
This study is looking at the best way to give malaria medications to young children with severe malnutrition and adults with HIV, to make sure they get the right dose for effective treatment and prevention of malaria.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kamuzu University of Health Sciences NIH-funded |
| Lab location | 1 site (Blantyre, Malawi) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $108,916 |
| NIH project number | 1K43TW012801-01 |
| Project ID | NIH-10979190 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include young children under 11 years old with severe acute malnutrition and adults over 21 years old who are living with HIV and receiving dolutegravir-based antiretroviral therapy.
✕Less likely to help
Patients who do not have severe acute malnutrition or are not living with HIV may not benefit from this research.
What this research studies
This research investigates how to best dose the antimalarial drugs artemether-lumefantrine and amodiaquine in young children suffering from severe acute malnutrition and adults living with HIV. The study will assess how these conditions affect the absorption and effectiveness of the medications, aiming to ensure that patients receive the right amount to effectively treat and prevent malaria. By conducting clinical trials, the research will gather important data on drug safety and pharmacokinetics in these vulnerable populations. The findings could lead to improved treatment protocols tailored to the needs of these specific groups.
Why it matters
Potential benefit: If successful, this research could lead to more effective malaria treatments for children with severe malnutrition and adults living with HIV, potentially reducing malaria-related morbidity and mortality in these populations.
How similar studies have gone: Previous research has shown that optimizing drug dosing in vulnerable populations can lead to significant improvements in treatment outcomes, suggesting that this approach has the potential for success.
Where this research is happening
-
Kamuzu University of Health Sciences
Blantyre, Malawi Active
Researchers
- Principal investigator: Banda, Clifford George — Kamuzu University of Health Sciences
- Study coordinator: Banda, Clifford George
Related research
Other NIH-funded projects on the same topics.
-
Azithromycin added to standard care for kids with severe malnutrition in Africa
This project tests whether giving azithromycin as an extra antibiotic to young children with uncomplicated severe acute malnutrition improves weight gain and recovery compared with amoxicillin or placebo.
-
Gut-Liver-Bone clues to growth problems in malnourished children
A study in malnourished children and a mouse model looks at how the gut, liver, and bone interact to cause growth faltering and tests a bile-acid therapy that could improve growth and reduce inflammation.
-
Azithromycin adjunct in kids with severe malnutrition in Africa
A randomized trial will compare azithromycin, amoxicillin, and placebo as adjunctive antibiotics for children with uncomplicated severe acute malnutrition to see which supports better weight gain and recovery.
-
Digital tools to fight adolescent malnutrition in schools (low-resource settings)
A school-based mobile health approach helps younger adolescents in low-resource areas improve nutrition and health behaviors.
-
How caregiver mental health affects recovery from severe malnutrition in young children
This project will track caregivers' depression and anxiety while their children get treatment for severe acute malnutrition to learn how caregiver mental health relates to child recovery and relapse.
-
Preventing Growth Problems in Poor Children by Treating Small Intestine Bacteria
A phase II effort in urban Bangladesh tests a treatment plan to stop growth failure and malnutrition in young children by addressing small intestinal bacterial overgrowth.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.